Corvex Management LP
CIK 0001535472 Name as filed on the most recent filing
Filed as Corvex Management LP (15)
51 transaction lines · from 15 filings · filed 2018-01-02 to 2026-05-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-15 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 27,408 acquired | 38.28 | 1,049,178.24 | Form 4, filing 0001011438-26-000351 | |
| 2026-05-15 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 18,865 acquired | 39.83 | 751,392.95 | Form 4, filing 0001011438-26-000351 | |
| 2026-05-14 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 88,107 acquired | 39.08 | 3,443,221.56 | Form 4, filing 0001011438-26-000351 | |
| 2026-05-14 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 51,893 acquired | 39.92 | 2,071,568.56 | Form 4, filing 0001011438-26-000351 | |
| 2026-05-13 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 94,074 acquired | 38.82 | 3,651,952.68 | Form 4, filing 0001011438-26-000351 | |
| 2026-05-13 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 70,926 acquired | 39.45 | 2,798,030.70 | Form 4, filing 0001011438-26-000351 | |
| 2026-05-11 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 252,734 acquired | 39.65 | 10,020,903.10 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-11 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 246,734 acquired | 38.91 | 9,600,419.94 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-11 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 532 acquired | 40.35 | 21,466.20 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-08 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 79,144 acquired | 40.67 | 3,218,786.48 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-08 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 73,104 acquired | 41.15 | 3,008,229.60 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-08 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 15,745 acquired | 38.00 | 598,310.00 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-08 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 3,396 acquired | 38.70 | 131,425.20 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-07 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 128,181 acquired | 35.46 | 4,545,298.26 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-07 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 123,393 acquired | 37.60 | 4,639,576.80 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-07 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 116,412 acquired | 38.46 | 4,477,205.52 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-07 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 94,356 acquired | 39.39 | 3,716,682.84 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-07 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 56,630 acquired | 40.46 | 2,291,249.80 | Form 4, filing 0001011438-26-000276 | |
| 2026-05-07 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 14,786 acquired | 36.33 | 537,175.38 | Form 4, filing 0001011438-26-000276 | |
| 2026-03-05 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 60,892 acquired | 81.37 | 4,954,782.04 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-05 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 47,623 acquired | 80.55 | 3,836,032.65 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-05 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 29,236 acquired | 82.06 | 2,399,106.16 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-05 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 1,971 acquired | 78.91 | 155,531.61 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-05 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 304 acquired | 77.96 | 23,699.84 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-03 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 19,686 acquired | 70.34 | 1,384,713.24 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-03 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 8,439 acquired | 71.48 | 603,219.72 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-03 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 921 acquired | 75.66 | 69,682.86 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-03 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 249 acquired | 75.99 | 18,921.51 | Form 4, filing 0001193125-26-094527 | |
| 2026-03-03 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 200 acquired | 72.00 | 14,400.00 | Form 4, filing 0001193125-26-094527 | |
| 2025-12-17 |
Vestis Corp VSTS |
P, Open-market purchase | 209,842 acquired | 6.79 | 1,424,827.18 | Form 4, filing 0001193125-25-323149 | |
| 2025-12-16 |
Vestis Corp VSTS |
P, Open-market purchase | 800,222 acquired | 6.81 | 5,449,511.82 | Form 4, filing 0001193125-25-323149 | |
| 2025-05-28 |
Vestis Corp VSTS |
P, Open-market purchase | 314,390 acquired | 6.03 | 1,895,771.70 | Form 4, filing 0000950170-25-078495 | |
| 2025-05-27 |
Vestis Corp VSTS |
P, Open-market purchase | 109,008 acquired | 6.05 | 659,498.40 | Form 4, filing 0000950170-25-078495 | |
| 2025-05-23 |
Vestis Corp VSTS |
P, Open-market purchase | 377,277 acquired | 5.89 | 2,222,161.53 | Form 4, filing 0000950170-25-078495 | |
| 2025-05-14 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 25,356 acquired | 59.81 | 1,516,542.36 | Form 4, filing 0000950170-25-073497 | |
| 2025-05-14 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 24,644 acquired | 60.52 | 1,491,454.88 | Form 4, filing 0000950170-25-073497 | |
| 2025-05-09 |
Vestis Corp VSTS |
P, Open-market purchase | 138,048 acquired | 6.32 | 872,463.36 | Form 4, filing 0000950170-25-069598 | |
| 2025-05-08 |
Vestis Corp VSTS |
P, Open-market purchase | 857,299 acquired | 6.11 | 5,238,096.89 | Form 4, filing 0000950170-25-069598 | |
| 2025-05-08 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 79,236 acquired | 55.69 | 4,412,652.84 | Form 4, filing 0000950170-25-069593 | |
| 2025-05-08 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 10,897 acquired | 56.96 | 620,693.12 | Form 4, filing 0000950170-25-069593 | |
| 2025-05-08 |
GeneDx Holdings Corp. WGS |
P, Open-market purchase | 9,867 acquired | 57.53 | 567,648.51 | Form 4, filing 0000950170-25-069593 | |
| 2024-05-24 |
Vestis Corp VSTS |
P, Open-market purchase | 100,000 acquired | 12.02 | 1,202,000.00 | Form 4, filing 0000950170-24-064791 | |
| 2024-05-23 |
Vestis Corp VSTS |
P, Open-market purchase | 100,000 acquired | 12.17 | 1,217,000.00 | Form 4, filing 0000950170-24-064179 | |
| 2024-05-21 |
Vestis Corp VSTS |
P, Open-market purchase | 100,000 acquired | 12.50 | 1,250,000.00 | Form 4, filing 0000950170-24-063216 | |
| 2024-05-20 |
Vestis Corp VSTS |
P, Open-market purchase | 116,044 acquired | 12.59 | 1,460,993.96 | Form 4, filing 0000950170-24-062627 | |
| 2024-05-08 |
Vestis Corp VSTS |
P, Open-market purchase | 622,346 acquired | 10.43 | 6,491,068.78 | Form 4, filing 0000950170-24-056034 | |
| 2024-05-07 |
Vestis Corp VSTS |
P, Open-market purchase | 996,300 acquired | 10.43 | 10,391,409.00 | Form 4, filing 0000950170-24-056034 | |
| 2024-05-06 |
Vestis Corp VSTS |
P, Open-market purchase | 1,828,009 acquired | 9.54 | 17,439,205.86 | Form 4, filing 0000950170-24-056034 | |
| 2023-11-15 |
GeneDx Holdings Corp. WGS |
S, Open-market sale | 883,742 disposed | 1.29 | 1,140,027.18 | Form 4, filing 0001213900-23-088336 | |
| 2017-12-29 |
Energen Corp EGN |
S, Open-market sale | 40,294 acquired | 57.66 | 2,323,428.60 | Form 4, filing 0000899243-18-000091 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Corvex Management LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001535472
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6